Alessandra Vitaliti

The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate

P Gergely, Barbara Nuesslein‐Hildesheim, Danilo Guerini et al. · British Journal of Pharmacology · 2012 · 304 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

Martin R. Farlow, Niels Andreasen, Marie‐Emmanuelle Riviere et al. · Alzheimer s Research & Therapy · 2015 · 143 citations · Full text

Life Sciences, Immunology, Neurology +17

Long‐Acting Octreotide and Prolonged‐Release Lanreotide Formulations Have Different Pharmacokinetic Profiles

B Astruc, Peter Marbach, Hakim Bouterfa et al. · The Journal of Clinical Pharmacology · 2005 · 122 citations

Medicine, Pharmacokinetics, Pharmacology +9

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +13

Increased expression of H/T-cadherin in tumor-penetrating blood vessels.

Lorenza Wyder, Alessandra Vitaliti, Henriette Schneider et al. · PubMed · 2000 · 81 citations

Medicine, Cell Biology, Oncology +14